Molecular and Cellular Pathology
British Journal of Cancer (2003) 88, 1566–1569. doi:10.1038/sj.bjc.6600929 www.bjcancer.com
Published online 13 May 2003
Activation of the Epstein–Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli
A MacNeil1,4, O P Sumba2, M L Lutzke1, A Moormann3 and R Rochford1
- 1Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
- 2Kenyan Medical Research Institute, Kisian, Kenya
- 3Division of Geographic Medicine, Case Western Reserve University, Cleveland, OH, USA
Correspondence: Dr R Rochford, Department of Epidemiology, University of Michigan, 109 Observatory St., Ann Arbor, MI 48109-2029, USA. E-mail: rochford@umich.edu
4Current address: National Immunization Program Epidemiology and Surveillance Division, Adult Vaccine-Preventable Diseases Branch, Center for Disease Control and Prevention, Atlanta, GA, USA.
Received 20 November 2002; Revised 6 February 2003; Accepted 10 February 2003.
Abstract
Exposure to the plant Euphorbia tirucalli has been proposed to be a cofactor in the genesis of endemic Burkitt's lymphoma (eBL). The purpose of this study was to examine the effects of unpurified E. tirucalli latex on Epstein–Barr virus (EBV) gene expression. A Burkitt lymphoma cell line was treated with varying dilutions of the latex and the effects on EBV gene expression were measured. We observed that the latex was capable of reactivating the EBV lytic cycle in a dose-dependent manner and at dilutions as low as 10-6. Simultaneous treatment of cells with E. tirucalli latex and the protein kinase C inhibitor 1-(5-isoquinolinesulphonyl)-2-methylpiperazine dihydrochloride blocked lytic cycle activation. These data suggest that environmental exposure to the latex of E. tirucalli could directly activate the EBV lytic cycle and provide further evidence of a role for E. tirucalli in the aetiology of eBL.
Keywords:
Epstein–Barr virus, Burkitt's lymphoma, E. tirucalli, viral gene expression
